Cumberland Pharmaceuticals INC (CPIX) — SC 13G Filings
All SC 13G filings from Cumberland Pharmaceuticals INC. Browse 1 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (1)
-
Cumberland Pharma CEO Kazimi Files SC 13G, Maintains Significant Stake
— Feb 9, 2024 Risk: low
A.J. Kazimi, the CEO of Cumberland Pharmaceuticals Inc., filed an Amendment No. 11 to Schedule 13G on February 9, 2024, indicating his beneficial ownership of t
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX